These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21439057)

  • 1. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).
    Hendriks M; Brewster L; Wit F; Bolarinwa OA; Odusola AO; Redekop W; Bindraban N; Vollaard A; Alli S; Adenusi P; Agbede K; Akande T; Lange J; Schultsz C
    BMC Public Health; 2011 Mar; 11():186. PubMed ID: 21439057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a patient centered cardiovascular health education program for insured patients in rural Nigeria (QUICK - II).
    Odusola AO; Hendriks M; Schultsz C; Stronks K; Lange J; Osibogun A; Akande T; Alli S; Adenusi P; Agbede K; Haafkens J
    BMC Public Health; 2011 Mar; 11():171. PubMed ID: 21418629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and quality of cardiovascular disease prevention within a community-based health insurance program in rural Nigeria: an operational cohort study.
    Hendriks ME; Bolarinwa OA; Wit FW; Brewster LM; Odusola AO; Rosendaal NT; Bindraban NR; Adenusi P; Agbede K; Lange JM; Akande TM; Schultsz C
    J Hypertens; 2015 Feb; 33(2):366-75. PubMed ID: 25380163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
    Hendriks ME; Bolarinwa OA; Nelissen HE; Boers AC; Gomez GB; Tan SS; Redekop W; Adenusi P; Lange JM; Agbede K; Akande TM; Schultsz C
    J Hypertens; 2015 Feb; 33(2):376-684. PubMed ID: 25380164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.
    Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB
    PLoS One; 2016; 11(6):e0157925. PubMed ID: 27348310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
    Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
    BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
    Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
    PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trial.
    Oti SO; van de Vijver SJ; Kyobutungi C; Gomez GB; Agyemang C; Moll van Charante EP; Brewster LM; Hendriks ME; Schultsz C; Ettarh R; Ezeh A; Lange J
    Trials; 2013 Dec; 14():409. PubMed ID: 24289751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.
    Mc Namara KP; George J; O'Reilly SL; Jackson SL; Peterson GM; Howarth H; Bailey MJ; Duncan G; Trinder P; Morabito E; Finch J; Bunker S; Janus E; Emery J; Dunbar JA
    BMC Health Serv Res; 2010 Sep; 10():264. PubMed ID: 20819236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang.
    Wei X; Zou G; Gong W; Yin J; Yu Y; Walley J; Zhang Z; King R; Chen K; Chong MK; Zee BC; Liu S; Tang J; Griffiths S; Yu M
    Trials; 2013 Oct; 14():354. PubMed ID: 24160442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.
    Le Goff D; Aerts N; Odorico M; Guillou-Landreat M; Perraud G; Bastiaens H; Musinguzi G; Le Reste JY; Barais M
    Int J Behav Nutr Phys Act; 2023 Jul; 20(1):93. PubMed ID: 37507692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk.
    Smith L; Atherly A; Campbell J; Flattery N; Coronel S; Krantz M
    BMC Public Health; 2019 Sep; 19(1):1234. PubMed ID: 31492118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal.
    Aryal A; Citrin D; Halliday S; Kumar A; Nepal P; Shrestha A; Nugent R; Schwarz D
    Glob Health Res Policy; 2020; 5():2. PubMed ID: 32016159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
    Patel B; Peiris DP; Patel A; Jan S; Harris MF; Usherwood T; Panaretto K; Lung T
    Med J Aust; 2020 Jul; 213(2):73-78. PubMed ID: 32594567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of national community organization cardiovascular prevention programs for high-risk women.
    Villablanca AC; Arline S; Lewis J; Raju S; Sanders S; Carrow S
    J Cardiovasc Transl Res; 2009 Sep; 2(3):306-20. PubMed ID: 19654887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for rural health insurance through community participation in India.
    Mathiyazhagan K
    Int J Health Plann Manage; 1998; 13(1):47-67. PubMed ID: 10178583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
    Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
    Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.